NewsGSK Reports Health Canada’s NDS Acceptance of Depemokimab for Asthma with Type 2 Inflammation and CRSwNPByRidhi RastogiMay 27, 20250Comments
NewsAI Medical Technology’s Dermalyser Receives European CE Mark Approval for Melanoma DetectionByRidhi RastogiMay 27, 20250Comments
NewsBio-Thera Solutions and Hikma Pharmaceuticals Receive the US FDA’s Approval for Starjemza (Biosimilar, Stelara)ByRidhi RastogiMay 27, 20250Comments
NewsAutolus Therapeutics’ Obecabtagene Autoleucel Receives the CHMP’s Positive Opinion for R/R B-Cell Acute Lymphoblastic Leukemia (B-ALL)ByRidhi RastogiMay 27, 20250Comments
VIEWPOINTSChronic Dermatologic Care: Baldo Scassellati Sforzolini from Galderma in Conversation with PharmaShotsBySaurabh ChaubeyMay 26, 20251Comment
NewsGenentech Reports P-III (STARGLO) Trial Data on Columvi for R/R Diffuse Large B-Cell Lymphoma (DLBCL)ByRidhi RastogiMay 26, 20250Comments
NewsLupin Collaborates with SteinCares to Commercialize Ranibizumab Biosimilar in Latin AmericaByRidhi RastogiMay 26, 20250Comments
NewsRoche’s Itovebi Regimen Secures the CHMP’s Positive Opinion for PIK3CA-mutated Breast CancerByRidhi RastogiMay 26, 20250Comments
